, /PRNewswire/ — MedicosBiotech proudly announces its recognition at CES 2025, the world’s premier technology event, as a recipient of the prestigious CES Innovation Award in the Digital Health category. This award honors excellence in innovation, technology, and design, spotlighting MedicosBiotech’s groundbreaking chronic wound care solution, Cure Silk.
Cure Silk revolutionizes chronic wound treatment by combining advanced artificial intelligence (AI) with spider silk protein-based therapeutic patches. This innovative solution empowers users through the Cure Silk App, which utilizes a smartphone camera to capture and analyze wound images. With AI-driven diagnostics, the app identifies wound types and severity, offering tailored treatment recommendations. This user-friendly technology ensures that anyone, even without medical expertise, can manage chronic wounds at home.
At the core of Cure Silk is its spider silk protein-based patch, a breakthrough innovation led by MedicosBiotech CEO, Dr. Wonmin Yoo. This patch is highly effective for treating stage 3–4 pressure ulcers and …